A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67
Titel:
A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67
Auteur:
Hahn, N.M. Zon, R.T. Yu, M. Ademuyiwa, F.O. Jones, T. Dugan, W. Whalen, C. Shanmugam, R. Skaar, T. Sweeney, C.J.